Humana Inc. (NYSE:HUM) Shares Sold by Federated Hermes Inc.

Federated Hermes Inc. lowered its position in Humana Inc. (NYSE:HUM) by 5.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 165,747 shares of the insurance provider’s stock after selling 9,727 shares during the period. Federated Hermes Inc. owned about 0.13% of Humana worth $75,881,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of HUM. Cibc World Market Inc. grew its position in shares of Humana by 4.0% during the 1st quarter. Cibc World Market Inc. now owns 5,709 shares of the insurance provider’s stock valued at $2,484,000 after acquiring an additional 217 shares during the period. Blair William & Co. IL grew its position in shares of Humana by 0.6% during the 1st quarter. Blair William & Co. IL now owns 5,660 shares of the insurance provider’s stock valued at $2,463,000 after acquiring an additional 32 shares during the period. Cetera Investment Advisers grew its position in shares of Humana by 0.5% during the 1st quarter. Cetera Investment Advisers now owns 4,906 shares of the insurance provider’s stock valued at $2,135,000 after acquiring an additional 26 shares during the period. Sequoia Financial Advisors LLC grew its position in shares of Humana by 19.0% during the 1st quarter. Sequoia Financial Advisors LLC now owns 615 shares of the insurance provider’s stock valued at $268,000 after acquiring an additional 98 shares during the period. Finally, Candriam Luxembourg S.C.A. grew its position in shares of Humana by 25.0% during the 1st quarter. Candriam Luxembourg S.C.A. now owns 29,809 shares of the insurance provider’s stock valued at $12,971,000 after acquiring an additional 5,964 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on HUM. Royal Bank of Canada decreased their price target on shares of Humana from $507.00 to $415.00 and set an “outperform” rating on the stock in a research note on Friday, January 26th. StockNews.com lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 26th. The Goldman Sachs Group decreased their target price on shares of Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research note on Wednesday, April 3rd. TD Cowen decreased their target price on shares of Humana from $427.00 to $396.00 and set a “buy” rating on the stock in a research note on Tuesday, April 2nd. Finally, Raymond James initiated coverage on shares of Humana in a research note on Friday, March 22nd. They issued a “market perform” rating on the stock. Eleven research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $465.42.

Humana Stock Up 0.4 %

Humana stock opened at $324.83 on Friday. Humana Inc. has a fifty-two week low of $299.23 and a fifty-two week high of $541.21. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.59 and a current ratio of 1.59. The firm has a 50 day moving average price of $343.55 and a 200 day moving average price of $425.01. The company has a market capitalization of $39.19 billion, a PE ratio of 16.39, a price-to-earnings-growth ratio of 1.90 and a beta of 0.45.

Humana (NYSE:HUM) last posted its earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share for the quarter, missing the consensus estimate of $0.76 by ($0.87). The company had revenue of $26.46 billion during the quarter, compared to analyst estimates of $25.47 billion. Humana had a net margin of 2.34% and a return on equity of 19.44%. The firm’s revenue for the quarter was up 17.9% on a year-over-year basis. During the same quarter last year, the business posted $1.62 EPS. Research analysts expect that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.09%. Humana’s dividend payout ratio (DPR) is 17.86%.

Insiders Place Their Bets

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was acquired at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the purchase, the director now directly owns 2,578 shares in the company, valued at approximately $946,358.02. The purchase was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.32% of the company’s stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.